Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

Nitroglycerin (NTG), a drug that has been in clinical use for more than a century, has a range of actions which make it of particular interest in an oncological setting. It is generally accepted that the main mechanism of action of NTG is via the production of nitric oxide (NO), which improves cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukhatme, Vidula, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vikas P, Pantziarka, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583240/
https://www.ncbi.nlm.nih.gov/pubmed/26435741
http://dx.doi.org/10.3332/ecancer.2015.568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583240/
https://www.ncbi.nlm.nih.gov/pubmed/26435741
http://dx.doi.org/10.3332/ecancer.2015.568

Ejemplares similares